Customer Center
Login | Register


Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More


Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.

Learn More


Luminex® Blog

Erasmus MC Publication Reports Evaluation of ARIES® Flu A/B & RSV Assay

Publication demonstrates effectiveness and ease of use for routine testing

Erasmus Medical Center in Rotterdam, The Netherlands, has a world-class virology department that serves as a consultation center for the World Health Organization, among many other prestigious affiliations. We are delighted to see that scientists from the Department of Viroscience at Erasmus MC recently published the results of a study evaluating the ARIES® System and Flu A/B & RSV CE-IVD Assay…”

Continue Reading…

We Are Luminex

We Are Luminex


At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health.

Watch more videos >

Luminex on Twitter

#ICYMI: Erasmus MC Publication reports evaluation of ARIES #Flu A/B & RSV Assay:
h J R
Study: New York City dirt rich in bacteria related to medical treatments by @WSJ @leHotz
h J R
Decline of multidrug-resistant Gram neg. infections with routine use of a multiple decontamination regimen in ICU:
h J R

Latest News

November 17
ARIES System and Flu A/B & RSV Assay Evaluated by Erasmus MC in New Publication

November 7
Luminex Corporation To Present At The 28th Annual Piper Jaffray Healthcare Conference

October 31
Luminex Corporation Reports Third Quarter 2016 Results; Raises Full Year Guidance

October 11
Luminex Corporation Third Quarter Earnings Release Scheduled for October 31, 2016

August 8
Luminex Corporation Receives FDA Emergency Use Authorization for Zika Virus Molecular Detection Assay

August 3
Luminex Corporation Receives FDA Clearance for New Molecular Test for Identification and Differentiation of Influenza A/B and Respiratory Syncytial Virus


SCASM Annual Meeting
October 26-29
La Jolla, CA

October 26-30
New Orleans, LA

UNY-AACC & CNY-CLMA Annual Conference
November 10-11
Verona, NY

AMP Annual Meeting
November 10-12
Charlotte, NC

xMAP® Connect
November 16-17
Amsterdam, NL